Matthias J Bahr, Michael P Manns. Show Affiliations »
Abstract
Mesh： See more » Antiviral Agents/administration & dosageHepatitis C, Chronic/drug therapyHepatitis C, Chronic/etiologyHepatitis C, Chronic/surgeryHumansInterferon alpha-2Interferon-alpha/administration & dosageLiver Cirrhosis/etiologyLiver Cirrhosis/prevention & controlLiver Cirrhosis/surgeryLiver Transplantation/adverse effectsPolyethylene GlycolsRecombinant ProteinsRecurrenceRibavirin/administration & dosage
Substances： See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRecombinant ProteinsPolyethylene GlycolsRibavirinpeginterferon alfa-2b
Year: 2004 PMID： 15030989 DOI： 10.1016/j.jhep.2004.01.018
Source DB: PubMed Journal: J Hepatol ISSN： 0168-8278 Impact factor: 25.083